Orchestra BioMed Holdings, Inc. (OBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 15M 30M 45M Q3 '24: 2.6M Q4 '24: 2.6M Q1 '25: 2.9M Q2 '25: 2.9M Q3 '25: 2.8M Q4 '25: 33.5M Q1 '26: 32.7M Q2 '26: 32M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 15M 30M 45M Q3 '24: 2.5M Q4 '24: 2.4M Q1 '25: 2.7M Q2 '25: 2.7M Q3 '25: 2.6M Q4 '25: 33.3M Q1 '26: 32.5M Q2 '26: 31.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '24: -60.1M Q4 '24: -64.3M Q1 '25: -68.8M Q2 '25: -71.3M Q3 '25: -75.2M Q4 '25: -51.8M Q1 '26: -55M Q2 '26: -58M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '24: -57.7M Q4 '24: -61M Q1 '25: -66.3M Q2 '25: -69.7M Q3 '25: -75.1M Q4 '25: -52.7M Q1 '26: -54.6M Q2 '26: -59M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 80K 160K 240K Q3 '24: 193K Q4 '24: 204K Q1 '25: 214K Q2 '25: 216K Q3 '25: 197K Q4 '25: 190K Q1 '26: 178K Q2 '26: 157K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q3 '24: -48M Q4 '24: -50.6M Q1 '25: -54.1M Q2 '25: -59.4M Q3 '25: -60.2M Q4 '25: -49M Q1 '26: -54.5M Q2 '26: -58.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q3 '24: -48.2M Q4 '24: -50.8M Q1 '25: -54.5M Q2 '25: -59.7M Q3 '25: -60.8M Q4 '25: -49.5M Q1 '26: -55.1M Q2 '26: -59.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q1 '24: 35.8M Q2 '24: 35.8M Q3 '24: 37.6M Q1 '25: 38.2M Q2 '25: 38.4M Q3 '25: 52.2M Q1 '26: 62.7M Q2 '26: 63.8M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q3 '24: -1.61 Q4 '24: -1.67 Q1 '25: -1.78 Q2 '25: -1.83 Q3 '25: -1.82 Q4 '25: -1.11 Q1 '26: -0.95 Q2 '26: -0.83 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.